Ann M Spungen Selected Research

Quadriplegia (Spastic Quadriplegia)

1/2020	Exoskeletal-Assisted Walking During Acute Inpatient Rehabilitation Leads to Motor and Functional Improvement in Persons With Spinal Cord Injury: A Pilot Study.
1/2018	Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia.
3/2011	Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia risks in persons with chronic tetraplegia: a randomized multicenter controlled trial.
11/2009	Breathing pattern and ventilatory control in chronic tetraplegia.
5/2009	Pulmonary function and spinal cord injury.
2/2009	Effect of hypotensive challenge on systemic hemodynamics and cerebral blood flow in persons with tetraplegia.
1/2009	Effects of acute nitric oxide synthase inhibition on lower leg vascular function in chronic tetraplegia.
1/2008	Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure.
1/2007	Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia.
11/2006	Salmeterol improves pulmonary function in persons with tetraplegia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann M Spungen Research Topics

Disease

29	Spinal Cord Injuries (Spinal Cord Injury) 03/2021 - 01/2004
12	Quadriplegia (Spastic Quadriplegia) 01/2020 - 01/2004
6	Paraplegia (Spastic Paraplegia) 01/2021 - 01/2004
3	Insulin Resistance 07/2021 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2018 - 01/2005
3	Dementia (Dementias) 05/2014 - 01/2010
2	Stroke (Strokes) 05/2014 - 01/2012
2	Pressure Ulcer (Bedsore) 05/2013 - 11/2010
2	Dyslipidemias (Dyslipidemia) 01/2012 - 03/2011
2	Cognitive Dysfunction 01/2012 - 01/2010
2	Vitamin D Deficiency 01/2011 - 01/2005
2	Cough 05/2009 - 11/2006
2	Paralysis (Palsy) 01/2007 - 07/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2018
1	Urinary Tract Infections (Urinary Tract Infection) 05/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2014
1	Ulcer 05/2013
1	Coronary Disease (Coronary Heart Disease) 10/2010
1	Vascular Diseases (Vascular Disease) 10/2010
1	Chronic Renal Insufficiency 01/2010
1	Fibrosis (Cirrhosis) 05/2009
1	Respiratory Hypersensitivity 05/2009
1	Infections 05/2009
1	Secondary Hyperparathyroidism 01/2009
1	Asthma (Bronchial Asthma) 11/2006
1	Bone Resorption 09/2005
1	Fasciculation (Fasciculations) 07/2005
1	Bradycardia 07/2005
1	Type 2 Diabetes Mellitus (MODY) 01/2005
1	Dizziness (Lightheadedness) 01/2005

Drug/Important Bio-Agent (IBA)

6	Neostigmine (Neostigmine Bromide)IBA 03/2021 - 01/2004
5	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 03/2021 - 01/2004
4	HDL CholesterolIBA 07/2021 - 03/2011
4	Bronchodilator Agents (Bronchodilators)IBA 01/2018 - 01/2004
4	Testosterone (Sustanon)FDA Link 01/2015 - 01/2011
4	Vitamin D FDA LinkGeneric 01/2011 - 01/2005
3	Triglycerides (Triacylglycerol)IBA 07/2021 - 10/2010
3	Cholinergic Antagonists (Anticholinergics)IBA 01/2018 - 07/2005
3	Insulin-Like Growth Factor I (IGF-1)IBA 09/2013 - 04/2006
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2009 - 01/2007
2	LipidsIBA 07/2021 - 07/2015
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2015
2	HDL LipoproteinsIBA 11/2018 - 10/2010
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 10/2008
2	Ipratropium (Ipratropium Bromide)FDA LinkGeneric 01/2018 - 05/2009
2	SolutionsIBA 11/2015 - 01/2004
2	Baclofen FDA LinkGeneric 09/2013 - 04/2006
2	Salmeterol Xinafoate (Serevent)FDA Link 05/2009 - 11/2006
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2009 - 01/2005
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2008 - 01/2007
2	arginine methyl esterIBA 01/2008 - 01/2007
1	Biomarkers (Surrogate Marker)IBA 07/2021
1	Glucose (Dextrose)FDA LinkGeneric 07/2021
1	Denosumab FDA Link 08/2020
1	N 30IBA 01/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018
1	Albuterol (Salbutamol)FDA LinkGeneric 01/2018
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2018
1	ElectrolytesIBA 11/2015
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 11/2015
1	MoviPrep FDA Link 10/2015
1	oxidized low density lipoproteinIBA 07/2015
1	Lipoproteins (Lipoprotein)IBA 07/2015
1	LDL CholesterolIBA 07/2015
1	Zoledronic Acid (Zometa)FDA Link 07/2015
1	chemotactic factor inactivatorIBA 05/2015
1	Insulin (Novolin)FDA Link 09/2013
1	Oxandrolone (Anavar)FDA LinkGeneric 05/2013
1	CarbohydratesIBA 01/2012
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	Niacin (Nicotinic Acid)FDA LinkGeneric 03/2011
1	Cholecalciferol (Vitamin D3)FDA Link 01/2011
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2010
1	Carbon DioxideIBA 11/2009
1	Methacholine Chloride (Methacholine)FDA Link 05/2009
1	Enalaprilat (Vasotec)FDA LinkGeneric 02/2009
1	CalciumIBA 01/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2008
1	BuffersIBA 01/2008
1	Saline SolutionIBA 01/2008
1	SuspensionsIBA 01/2007
1	Growth Hormone (Somatotropin)IBA 01/2007
1	Estradiol (Delestrogen)FDA LinkGeneric 06/2006
1	collagen type I trimeric cross-linked peptideIBA 09/2005
1	MineralsIBA 09/2005
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2005
1	Pamidronate (Aredia)FDA LinkGeneric 05/2005
1	ReninIBA 01/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2005
1	Metaproterenol (Alupent)FDA LinkGeneric 01/2004

Therapy/Procedure

5	Therapeutics 01/2015 - 01/2005
3	Renal Dialysis (Hemodialysis) 05/2014 - 01/2010
2	Intravenous Administration 01/2018 - 10/2008
1	Cutaneous Administration 01/2018
1	Aftercare (After-Treatment) 05/2013
1	Activities of Daily Living (ADL) 03/2013
1	Negative-Pressure Wound Therapy 11/2010
1	Contraindications 11/2010
1	Sympathectomy (Sympathectomies) 07/2006